Ascentage Pharma Group International (FRA:36X)

Revenue by Product

Financials in millions HKD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Intellectual Property Rights	735.55M
Pharmaceutical Products	282.80M
Pharmaceutical Products Growth	32.24%
Commercialization Rights	40.64M
Commercialization Rights Growth	41.20%
Other	4.24M
Other Growth	60.06%

Revenue by Geography

Financials in millions HKD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Switzerland	735.55M
China	327.69M
China Growth	33.59%